首页> 美国卫生研究院文献>Annals of the Rheumatic Diseases >Circulating soluble adhesion molecules in patients with giant cell arteritis. Correlation between soluble intercellular adhesion molecule-1 (sICAM-1) concentrations and disease activity
【2h】

Circulating soluble adhesion molecules in patients with giant cell arteritis. Correlation between soluble intercellular adhesion molecule-1 (sICAM-1) concentrations and disease activity

机译:巨细胞性动脉炎患者中的循环可溶性粘附分子。可溶性细胞间粘附分子-1(sICAM-1)浓度与疾病活动性的相关性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

OBJECTIVE—To evaluate whether changes in concentrations of circulating adhesion molecules are related to disease activity in patients with giant cell arteritis (GCA).
METHODS—A sandwich ELISA was used to measure soluble intercellular adhesion molecule-1 (sICAM-1), sICAM-3, vascular cell adhesion molecule-1 (sVCAM-1), E-selectin (sE-selectin), and L-selectin (sL-selectin) in serum and plasma samples from patients with GCA. A cross sectional study was performed on 64 GCA patients at different activity stages and on 35 age and sex matched healthy donors. Thirteen of these patients were evaluated at the time of diagnosis and serially during follow up.
RESULTS—At the time of diagnosis, sICAM-1 concentrations were significantly higher in active GCA patients than in controls (mean (SD) 360.55 (129.78) ng/ml versus 243.25 (47.43) ng/ml, p<0.001). In contrast, sICAM-3, sVCAM-1, sE-selectin, and sL-selectin values did not differ from those obtained in normal donors. With corticosteroid administration, a decrease in sICAM-1 concentrations was observed, reaching normal values when clinical remission was achieved (263.18 (92.7) ng/ml globally, 293.59 (108.39) ng/ml in the group of patients in recent remission, and 236.83 (70.02) ng/ml in those in long term remission). In the 13 patients followed up longitudinally, sICAM-1 values also normalised with clinical remission (225.87 (64.25) ng/ml in patients in recent remission, and 256.29 (75.15) ng/ml in those in long term remission).
CONCLUSIONS—Circulating sICAM-1 concentrations clearly correlate with clinically apparent disease activity in GCA patients. Differences with results previously found in patients with other vasculitides may indicate that different pathogenic mechanisms contribute to vascular inflammation in different disorders.

Keywords: adhesion molecules; giant cell arteritis; inflammation
机译:目的—评估巨细胞性动脉炎(GCA)患者循环黏附分子浓度的变化是否与疾病活动相关。
方法—夹心ELISA用于测量可溶性细胞间黏附分子-1(sICAM-1 ),GCA患者血清和血浆样本中的sICAM-3,血管细胞粘附分子1(sVCAM-1),E-选择素(sE-selectin)和L-选择素(sL-selectin)。对64名GCA患者处于不同活动阶段以及35名年龄和性别相匹配的健康捐献者进行了一项横断面研究。在诊断时和随访期间对其中的13名患者进行了评估。
结果-在诊断时,活动性GCA患者的sICAM-1浓度显着高于对照组(平均值(SD)360.55。 129.78)ng / ml与243.25(47.43)ng / ml,p <0.001)。相反,sICAM-3,sVCAM-1,sE-选择素和sL-选择素的值与正常供体中的值没有差异。服用皮质类固醇激素后,观察到sICAM-1浓度降低,达到临床缓解后达到正常值(全球263.18 (92.7)ng / ml,在293组中为293.59(108.39)ng / ml)。最近缓解的患者,长期缓解的患者为236.83(70.02)ng / ml)。在纵向随访的13例患者中,sICAM-1值也随着临床缓解而恢复正常(近期缓解的患者为225.87 (64.25)ng / ml,长期缓解的患者为256.29(75.15)ng / ml结论-循环中sICAM-1的浓度与GCA患者临床上明显的疾病活动密切相关。与先前在其他血管炎患者中发现的结果不同可能表明在不同疾病中,不同的致病机制可能导致血管炎症。

巨细胞动脉炎炎

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号